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Laue et al., page 595
Skeletal development is not what comes to mind for most
of us when we think of vitamin A. Rather, our minds prob-
ably jump immediately to carrots and their ability to
promote night vision. Although it’s true that ß-carotene,
a form of vitamin A, is important for vision, research
has identified a role for vitamin A in many cells outside
of the retina. For example, retinoic acid (RA) has long
been known to help mediate patterning during early
development. This is true for species from fish to humans.
Rat studies have also pointed to a role for vitamin A in
fertility. Additionally, research has implicated RA as an
important mediator of axial and appendicular skeletal
development. But, like most things in life, moderate
levels of vitamin A are needed for our bodies to operate
efficiently. Too little vitamin A can lead to vision and
patterning defects, whereas too much vitamin A can cause
toxicity. Thus, in addition to producing RA, our bodies
produce enzymes that metabolize excess RA. In this issue,
Laue and colleagues utilize autozygosity mapping and
sequencing to identify mutations in CYP26B1 in a family
and an individual with skeletal malformations. CYP26B1
encodes an enzyme involved in RA catabolism. Their
work highlights the important role of vitamin A in skel-
etal differentiation and ossification and emphasizes the
importance of maintaining proper levels of this multifac-
eted vitamin.Genes with Many Functions
Sivakumaran et al., page 607
Molecular biology began with the concept that one gene
is responsible for producing one enzyme. This one gene-
one enzyme hypothesis was soon found to be too simple
and was modified to one gene-one polypeptide. We now
know that this hypothesis is also too simple. Thanks to
intricate splicing mechanisms, one gene can in fact
code for many different proteins. Likewise, one gene
can influence many different phenotypes. So is it too
with genetic variants. This pleiotropy is apparent to inves-
tigators looking for SNP associations with immunological
diseases and other traits as genome-wide association
studies (GWASs) have shown the same SNP, or SNPs1Deputy Editor, AJHG
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different phenotypes. But just how many genes or SNPs
in our genome can truly be considered pleiotropic? In
this issue, Sivakumaran and colleagues tackle this ques-
tion by systematically evaluating all variants identified
and replicated in GWASs to associate with more than
one phenotype. Their analysis shows that approximately
17% of all genes and 5% of all SNPs demonstrate pleiot-
ropy. They catalog the genetic regions most likely to
contain pleiotropic variants, disease classes most associ-
ated with pleiotropy, and phenotypes linked to pleio-
tropic genes. This analysis confirms the interrelatedness
of different diseases and genetic traits and disproves any
one gene-one function hypothesis.Pressure to Find Risk Factors
Brown et al., page 619
The aorta is the largest artery in the body and has a hefty
job to do. It carries blood away from the heart and delivers
oxygen throughout the body. With this great responsi-
bility comes great pressure, literally. Blood pressure is
a measure of arterial pressure and is highest in the aorta.
Although arterial walls are designed to distend to handle
the pressure of the blood pumping out from the heart,
they can only take so much. When the aorta swells to
more than 1.5 times its normal diameter, it is considered
an aneurysm. The risk of aneurysm is that it could
rupture, leading to internal hemorrhage and possibly
death. A variety of genetic and environmental factors are
thought to contribute to the risk of aneurysm such as
age, smoking habits, and sex, with males being more
likely to develop aneurysms. Family history is a strong
risk factor for some types of aneurysms, including abdom-
inal aortic aneurysm (AAA). Although hypertension and
hypercholesterolemia are clear risk factors for many arte-
rial diseases, they have been inconsistently associated
with AAA risk. In fact, much work is still needed to iden-
tify the factors contributing to the risk of AAA. In this
issue, Brown and colleagues conduct a genome-wide asso-
ciation study to identify genetic risk variants for AAA.
They identify a SNP in LRP1 that associates specifically
with this condition. It is hoped that this information
will lead to improved therapeutic and preventative
approaches.Genetics. All rights reserved.
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Eye on MicroRNAs
Hughes et al., page 628
MicroRNAs (miRNAs) are small regulatory strands of RNA.
They bind complementary sequences within regulatory
regions of transcribed genes leading to suppression of
translation or degradation of mRNA. miRNAs have a
remarkably low rate of evolution and are thought to have
arisen as a means to more finely regulate transcription.
Strikingly, miRNAs have a clear distinction only between
the plant and animal kingdoms. Although miRNAs in
the plant kingdom have nearly perfect complimentarity
with target sequences, miRNAs in metazoans are only
complementary to a few bases, termed the seed region.
This provides enough plasticity that a single miRNA may
be capable of regulating multiple transcripts in humans
and other metazoans. Increasing the complexity of
miRNAs, many have tissue and/or temporal expression.
For example, MIR184 encodes a miRNA (miR-184)
primarily localized in the brain, testes, and certain cells
of the corneal and lens epithelium of the eye. In this issue,
Hughes and colleagues identify a mutation in the seed
region of MIR184 in a large, multigenerational family
afflicted with keratoconus (a condition of corneal degener-
ation) and early-onset cataracts. The phenotype is attrib-
uted to altered regulation of miR-148 targets. To date,
only one other miRNA has been reported to be mutated
in a Mendelian disease, MIR96 in familial deafness. As
the recognition of miRNAs is quite new, it is likely that
more and more miRNA sequences will be implicated in
genetic conditions.592 The American Journal of Human Genetics 89, 591–592, NovembAiding the Diagnosis of Variant Phenotypes
Clayton-Smith et al., page 675
Imagine a person coming into the clinician’s office having
a certain set of complaints, concerns, and looks. What
diagnosis should this person be given? Is this something
the clinician has seen before? Are these phenotypes
described together in the literature? Is it a new syndrome?
Although there are guidelines to follow in making a diag-
nosis, identifying the correct syndrome is not always
clear-cut. In 1986, Ohdo and colleagues described what
they considered a new syndrome in a family presenting
with narrow eyes (blepharophimosis), an undersized jaw
(micrognathia), a small head (microcephaly), and growth
retardation. This phenotypic combination was then
known as Ohdo syndrome. Within a few years, Say and
Barber, Biesecker, Young and Simpson, and others
described families with similar features. In 2006, Verloes
and colleagues proposed a classification of individuals
presenting with blepharophimosis-mental retardation
syndromes (BMRS), including Ohdo and its variants. In
this issue, Clayton-Smith and colleagues investigate the
genetic cause of 19 individuals having a presumed
diagnosis of BMRS Say-Barber-Biesecker-Young-Simpson
(SBBYS) type. The 12 individuals having typical features
of BMRS SBBYS type were all found to have mutations in
KAT6B. These findings indicate that this syndrome is well
defined and that KAT6B mutations may be very common
in such individuals. Identifying the genetic cause of these
complicated syndromes will surely aid in making correct
diagnoses in such challenging cases.er 11, 2011
